Allmed Solutions Ltd Cash Flow Conversion Efficiency
Allmed Solutions Ltd cash flow conversion efficiency. Based on the latest financial reports, Allmed Solutions Ltd (ALMD) has a cash flow conversion efficiency ratio of -0.241x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-6.77 Million ≈ $-18.14K USD) by net assets (ILA28.07 Million ≈ $75.25K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Allmed Solutions Ltd (2008–2025)
Cash flow conversion efficiency of Allmed Solutions Ltd from 2008 to 2025. This chart illustrates how Allmed Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALMD stock price and chart for real-time trading data and today's change.
Allmed Solutions Ltd Cash Flow Conversion Ratio Explained
Allmed Solutions Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Allmed Solutions Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Allmed Solutions Ltd ranked by their cash flow conversion efficiency. Also see Allmed Solutions Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tay Ninh Cable Car Tour Co.
VN:TCT
|
-0.003x |
|
Melbana Energy Ltd
AU:MAY
|
-0.017x |
|
Korea Plasma Technology U Co.Ltd
KQ:054410
|
0.004x |
|
Wise Group AB
ST:WISE
|
0.075x |
|
Oxford BioMedica PLC
LSE:OXB
|
0.072x |
|
Nimy Resources Ltd
AU:NIM
|
-0.130x |
|
Focus Dynamics Group Bhd
KLSE:0116
|
0.047x |
|
Green Technology Metals Ltd
AU:GT1
|
-0.017x |
Annual Cash Flow Conversion Efficiency for Allmed Solutions Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Allmed Solutions Ltd from 2008 to 2025. Review free cash flow generation of Allmed Solutions Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA28.07 Million ≈ $75.25K |
ILA-12.08 Million ≈ $-32.39K |
-0.430x | -125.38% |
| 2024-12-31 | ILA42.02 Million ≈ $112.65K |
ILA-8.03 Million ≈ $-21.51K |
-0.191x | -249.81% |
| 2023-12-31 | ILA55.97 Million ≈ $150.06K |
ILA7.14 Million ≈ $19.13K |
0.127x | +167.35% |
| 2022-12-31 | ILA53.96 Million ≈ $144.67K |
ILA-10.21 Million ≈ $-27.39K |
-0.189x | -80.81% |
| 2021-12-31 | ILA52.31 Million ≈ $140.25K |
ILA-5.48 Million ≈ $-14.68K |
-0.105x | +42.08% |
| 2020-12-31 | ILA48.77 Million ≈ $130.76K |
ILA-8.82 Million ≈ $-23.64K |
-0.181x | +17.04% |
| 2019-12-31 | ILA56.58 Million ≈ $151.69K |
ILA-12.33 Million ≈ $-33.05K |
-0.218x | +55.35% |
| 2018-12-31 | ILA32.83 Million ≈ $88.02K |
ILA-16.02 Million ≈ $-42.96K |
-0.488x | -2.71% |
| 2017-12-31 | ILA38.76 Million ≈ $103.91K |
ILA-18.42 Million ≈ $-49.38K |
-0.475x | -5.08% |
| 2016-12-31 | ILA38.19 Million ≈ $102.39K |
ILA-17.27 Million ≈ $-46.30K |
-0.452x | -28.55% |
| 2015-12-31 | ILA45.13 Million ≈ $120.98K |
ILA-15.87 Million ≈ $-42.56K |
-0.352x | +40.54% |
| 2014-12-31 | ILA32.16 Million ≈ $86.22K |
ILA-19.03 Million ≈ $-51.01K |
-0.592x | -33.36% |
| 2013-12-31 | ILA30.22 Million ≈ $81.02K |
ILA-13.41 Million ≈ $-35.94K |
-0.444x | -1.62% |
| 2012-12-31 | ILA67.29 Million ≈ $180.40K |
ILA-29.37 Million ≈ $-78.75K |
-0.437x | -141.17% |
| 2011-12-31 | ILA72.36 Million ≈ $193.98K |
ILA-13.10 Million ≈ $-35.11K |
-0.181x | +43.58% |
| 2010-12-31 | ILA26.29 Million ≈ $70.47K |
ILA-8.43 Million ≈ $-22.61K |
-0.321x | -102.04% |
| 2009-12-31 | ILA10.83 Million ≈ $29.04K |
ILA-1.72 Million ≈ $-4.61K |
-0.159x | +61.70% |
| 2008-12-31 | ILA14.19 Million ≈ $38.04K |
ILA-5.88 Million ≈ $-15.77K |
-0.415x | -- |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more